NIKOLIC, Dragana
 Distribuzione geografica
Continente #
NA - Nord America 96
EU - Europa 41
AS - Asia 13
AF - Africa 3
OC - Oceania 1
Totale 154
Nazione #
US - Stati Uniti d'America 96
IT - Italia 32
CN - Cina 9
RS - Serbia 6
EG - Egitto 3
SG - Singapore 3
AT - Austria 2
AU - Australia 1
FR - Francia 1
IR - Iran 1
Totale 154
Città #
Belgrade 6
Ashburn 4
Council Bluffs 4
Milan 4
Cairo 3
Pagani 3
Bari 2
Bologna 2
Catania 2
Forest City 2
Pandino 2
Romola 2
Shanghai 2
Singapore 2
Villaromagnano 2
Zhengzhou 2
Boydton 1
Pisa 1
Quartu Sant'Elena 1
Rome 1
San Severo 1
Sandston 1
Santa Clara 1
Springfield 1
Totale 52
Nome #
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes 14
Crithmum maritimum Extract Restores Lipid Homeostasis and Metabolic Profile of Liver Cancer Cells to a Normal Phenotype 10
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 10
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 10
Anti-inflammatory properties of an aldehydes-enriched fraction of grapefruit essential oil 8
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 8
An overview of statin-induced myopathy and perspectives for the future 7
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia 7
Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect 7
Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study 7
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 6
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors 5
Weight loss programmes using low carbohydrate diets to control the cardiovascular risk in adolescents (Review) 5
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 4
Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers 4
Uric acid metabolism in pre-hypertension and the metabolic syndrome 4
An evaluation of RVX-208 for the treatment of atherosclerosis 3
PPAR agonists, atherogenic dyslipidemia and cardiovascular risk 3
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms 3
The Role of Nutraceuticals in Statin Intolerant Patients 3
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 3
Peroxisome proliferator-activated receptors and atherosclerosis 3
Preliminary results of citraves™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study 3
Exosomal Heat Shock Proteins as New Players in Tumour Cell-to-Cell Communication 3
Serum low density lipoprotein subclasses in asthma 3
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis 3
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 3
Involvement of the ADAM 12 in thrombin-induced rat's VSMCs proliferation 3
Novel anti-obesity drugs and plasma lipids 3
Statins and new-onset diabetes 3
Small, dense LDL: an update 3
Serum lipoproteins are not associated with the severity of asthma 3
EXOSOMES: PROMISING NON-INVASIVE DIAGNOSTIC AND THERAPEUTIC TOOLS 3
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches 3
Adipokines and lipoproteins: Modulation by antihyperglycemic and hypolipidemic agents 3
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 3
The role of fibrate treatment in dyslipidemia: an overview 3
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials 3
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel 2
Can the effects of gender, menopause and ageing on lipid levels be differentiated? 2
Emerging approaches for the treatment of hypertriglyceridemia 2
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality 2
Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel 2
Periodontitis, blood lipids and lipoproteins 2
Statin treatment in the elderly: how much do we know? 2
Natural approaches in metabolic syndrome management 2
Psoriasis and acute coronary syndrome risk 2
Lifestyle recommendations for the prevention and management of metabolic syndrome: An international panel recommendation 2
Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome 2
Nutraceuticals as lipid-lowering treatment in pregnancy and their effects on the metabolic syndrome 2
Nutraceuticals as an important part of combination therapy in dyslipidaemia 2
Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits 2
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease 2
Should low high-density lipoprotein cholesterol (HDL-C) be treated? 2
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan 2
Incretin-based therapies, glucometabolic health and endovascular inflammation 2
Incretins, pregnancy, and gestational diabetes 2
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 2
ETC-1002: A future option for lipid disorders? 2
Drug evaluation: The combination of fenofibrate and simvastatin for the treatment of dyslipidemia: When and for whom? 2
IMPROVE-IT: What have we learned? 2
The extra-glycemic effects of liraglutide: Focus on cardiometabolic markers 2
Gestational diabetes and the metabolic syndrome: can obesity and small, dense low density lipoproteins be key mediators of this association? 2
The effect of bergamot on dyslipidemia 2
Effects of chitosan on plasma lipids and lipoproteins: A 4-month prospective pilot study 2
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 2
Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: A prospective pilot study 2
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy 2
Nutraceuticals as new therapeutic strategies for health and wellbeing 2
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 2
Regulation of inducible Nitric Oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure 2
Oxidative stress and the role of antioxidative treatment in diabetes mellitus 2
The dissociation of the Hsp60/pro-Caspase-3 complex by bis(pyridyl)oxadiazole copper complex (CubipyOXA) leads to cell death in NCI-H292 cancer cells 2
Management of Statin Intolerance in 2018: Still More Questions Than Answers 2
Alcoholic liver cirrhosis, more than a simple hepatic disease - A brief review of the risk factors associated with alcohol abuse 2
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children 2
Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives 2
Subfractions and subpopulations of HDL: An update 2
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 2
LDL and HDL subfractions, dysfunctional HDL: treatment options 2
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: Current knowledge and future perspective 2
Intensive LDL-cholesterol lowering therapy and neurocognitive function 2
Anti-cytokine therapy for prevention of atherosclerosis 1
Totale 271
Categoria #
all - tutte 4.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.377


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202393 0 0 0 0 0 0 0 0 0 0 90 3
2023/2024114 0 0 1 80 0 3 0 2 7 3 5 13
2024/202564 15 3 38 8 0 0 0 0 0 0 0 0
Totale 271